scispace - formally typeset
I

Iris E. C. Sommer

Researcher at University Medical Center Groningen

Publications -  454
Citations -  20580

Iris E. C. Sommer is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Schizophrenia & Medicine. The author has an hindex of 68, co-authored 394 publications receiving 16545 citations. Previous affiliations of Iris E. C. Sommer include University of Toronto & University of Michigan.

Papers
More filters
Journal ArticleDOI

Instrumental measurements of spontaneous dyskinesia and schizotypy in subjects with auditory verbal hallucinations and healthy controls

TL;DR: A greater proportion of subjects with dyskinesia in the group with auditory verbal hallucinations than in the control subjects is found, in agreement with the concept of psychosis as a continuous phenomenon and with movement disorders being an integral part of psychosis.
Book ChapterDOI

Hallucinations of Bodily Sensation

TL;DR: This chapter provides a classification of those various phenomena, such as tactile hallucinations, somatic hallucinations, sexual hallucinations, the coenesthesiopathies, proprioceptive hallucinations, kinesthetic hallucinations, vestibular hallucinations, hallucinated pain, and thermal hallucinations, and highlights what is known about their neurobiological underpinnings.
Journal ArticleDOI

Draining the pond and catching the fish: Uncovering the ecosystem of auditory verbal hallucinations

TL;DR: It is proposed that the mediation of AVH in the context of schizophrenia spectrum disorders involves the attribution of an excess of negative salience by anterior-cingulate areas to linguistic input from Broca's right homologue, followed by subsequent processing errors in areas further ‘downstream’ the causal chain of events.
Journal ArticleDOI

A Systematic Review on the Effects of Different Types of Probiotics in Animal Alzheimer's Disease Studies

TL;DR: The results of this animal review underline the potential of probiotic therapy as a treatment option in AD, as positive improvements were found on almost all outcomes.